Aspirin in ET:will twice a day keep thrombosis away?

Evan M. Braunstein, Shruti Chaturvedi

Research output: Contribution to journalReview articlepeer-review


In this issue of Blood, Rocca et al show that aspirin insensitivity or incomplete platelet inhibition with standard once-per-day low-dose aspirin in patients with essential thrombocythemia (ET) is overcome by twice-per-day dosing of low-dose aspirin without an increase in adverse effects. This presents an attractive strategy for improving vascular outcomes in ET.1.

Original languageEnglish (US)
Pages (from-to)151-153
Number of pages3
Issue number2
StatePublished - Jul 9 2020

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Aspirin in ET:will twice a day keep thrombosis away?'. Together they form a unique fingerprint.

Cite this